Achdiat PA, Suwarsa O, Hidayat YM, Shafiee MN, Dwiyana RF, Hindritiani R, Sutedja E, Pudjiati SR, Hilmanto D, Dhamayanti M, Parwati I, Maharani RH, Sutedja EK, Avriyanti E, Yunitasari

ImmunoTargets and Therapy 2024, 13:123-150

Published Date: 5 March 2024

Original Research

Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations

Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M

ImmunoTargets and Therapy 2024, 13:111-121

Published Date: 26 February 2024

Review

Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks

Rajabally YA

ImmunoTargets and Therapy 2024, 13:99-110

Published Date: 26 February 2024

Commentary

Males’ Access to Human Papillomavirus Vaccination in Resource-Limited Settings

Gezimu W, Bekele F, Bekana T, Demeke A

ImmunoTargets and Therapy 2024, 13:95-98

Published Date: 17 February 2024

Original Research

The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study

Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J

ImmunoTargets and Therapy 2024, 13:75-94

Published Date: 8 February 2024

Original Research

Identification of CXC Chemokine Receptor 2 (CXCR2) as a Novel Eosinophils-Independent Diagnostic Biomarker of Pediatric Eosinophilic Esophagitis by Integrated Bioinformatic and Machine-Learning Analysis

Wu J, Duan C, Han C, Hou X

ImmunoTargets and Therapy 2024, 13:55-74

Published Date: 2 February 2024

Original Research

Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study

Luo Q, Dong Y, Liu P, He C, Chen L, Zhang K, Pan C, Gao Y, Qin T

ImmunoTargets and Therapy 2024, 13:45-54

Published Date: 1 February 2024

Original Research

Unveiling Dynamic Changes and Regulatory Mechanisms of T Cell Subsets in Sepsis Pathogenesis

Jiang C, Chen J, Sun T, Xu J, Zhu H, Chen J

ImmunoTargets and Therapy 2024, 13:29-44

Published Date: 1 February 2024

Original Research

In-vivo Immunomodulatory Activities of Essential Oils of Artemisia abyssinica and Lepidium sativum in Mice

Ayenew KD, Ayalew A, Wondmkun YT, Tsige AW, Wolde A, Sewale Y, Belihu GD, Fekade E, Habteweld HA

ImmunoTargets and Therapy 2024, 13:15-27

Published Date: 23 January 2024

Review

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer

Li Y, Gu Y, Yang P, Wang Y, Yu X, Li Y, Jin Z, Xu L

ImmunoTargets and Therapy 2024, 13:1-14

Published Date: 9 January 2024

Case report

Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease

Wang CR, Lin WC, Wong TW

ImmunoTargets and Therapy 2023, 12:187-192

Published Date: 20 December 2023

Review

Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician

Semalulu T, Tago A, Zhao K, Tselios K

ImmunoTargets and Therapy 2023, 12:175-186

Published Date: 8 December 2023

Original Research

NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Huang Q, Cao H, Yao Q, Zhou X, Li H, Bai Q, Hu H

ImmunoTargets and Therapy 2023, 12:165-173

Published Date: 5 December 2023

Original Research

The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis

Cai XQ, Huang Q, Zhang TP

ImmunoTargets and Therapy 2023, 12:149-163

Published Date: 24 November 2023

Original Research

Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes

Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C

ImmunoTargets and Therapy 2023, 12:135-147

Published Date: 23 November 2023

Original Research

Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis

Zhao J, Hao S, Li Y, Liu X, Liu Z, Zheng C, Han D

ImmunoTargets and Therapy 2023, 12:113-133

Published Date: 11 November 2023

Review

Globoid Cell Leukodystrophy (Krabbe Disease): An Update

Maghazachi AA

ImmunoTargets and Therapy 2023, 12:105-111

Published Date: 31 October 2023

Review

Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy

Siddiqui K, Nawaz SS

ImmunoTargets and Therapy 2023, 12:91-103

Published Date: 29 September 2023

Review

Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G

ImmunoTargets and Therapy 2023, 12:79-89

Published Date: 26 July 2023

Letter

Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]

Wiggins S, Levit NA

ImmunoTargets and Therapy 2023, 12:77-78

Published Date: 25 May 2023

Original Research

Association of Toll-like Receptors 1, 2, 4, 6, 8, 9 and 10 Genes Polymorphisms and Susceptibility to Pulmonary Tuberculosis in Sudanese Patients

Mhmoud NA

ImmunoTargets and Therapy 2023, 12:47-75

Published Date: 6 April 2023

Review

Novel Immunotherapies for Myasthenia Gravis

Nair SS, Jacob S

ImmunoTargets and Therapy 2023, 12:25-45

Published Date: 4 April 2023

Case report

A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX

Zhu J, Li G, Zhang Z, Wang Y

ImmunoTargets and Therapy 2023, 12:17-23

Published Date: 19 February 2023

Original Research

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L

ImmunoTargets and Therapy 2023, 12:1-16

Published Date: 4 January 2023

Review

β-Glucan “Trained Immunity” Immunomodulatory Properties Potentiate Tissue Wound Management and Accelerate Fitness Recover

Renke G, Baesso T, Paes R, Renke A

ImmunoTargets and Therapy 2022, 11:67-73

Published Date: 17 October 2022

Review

A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects

Celik M, Fuehrlein B

ImmunoTargets and Therapy 2022, 11:55-66

Published Date: 29 September 2022

Review

The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome

Macdougall JD, Thomas KO, Iweala OI

ImmunoTargets and Therapy 2022, 11:37-54

Published Date: 15 September 2022

Review

Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2

Wang LG, Wang L

ImmunoTargets and Therapy 2022, 11:23-35

Published Date: 18 May 2022

Review

Immunotargets and Therapy for Prurigo Nodularis

Labib A, Ju T, Vander Does A, Yosipovitch G

ImmunoTargets and Therapy 2022, 11:11-21

Published Date: 26 April 2022

Review

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma

Lin AY, Schnitter JM, Gordon LI

ImmunoTargets and Therapy 2022, 11:1-10

Published Date: 23 February 2022

Review

Pathophysiology of Non-IgE-Mediated Food Allergy

Zhang S, Sicherer S, Berin MC, Agyemang A

ImmunoTargets and Therapy 2021, 10:431-446

Published Date: 29 December 2021

Review

Understanding and Managing Severe Asthma in the Context of COVID-19

Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M

ImmunoTargets and Therapy 2021, 10:419-430

Published Date: 11 December 2021

Review

The Role of IL-17 Cytokines in Psoriasis

Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T

ImmunoTargets and Therapy 2021, 10:409-418

Published Date: 24 November 2021

Review

Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies

Karmakar S, Pal P, Lal G

ImmunoTargets and Therapy 2021, 10:387-407

Published Date: 1 November 2021

Review

The Role of Complement in Synaptic Pruning and Neurodegeneration

Gomez-Arboledas A, Acharya MM, Tenner AJ

ImmunoTargets and Therapy 2021, 10:373-386

Published Date: 24 September 2021

Review

Immunotherapy of Multiple Myeloma: Promise and Challenges

Abramson HN

ImmunoTargets and Therapy 2021, 10:343-371

Published Date: 9 September 2021

Review

Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis

Arneson LC, Carroll KJ, Ruderman EM

ImmunoTargets and Therapy 2021, 10:333-342

Published Date: 28 August 2021

Review

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20

Levy M, Mealy MA

ImmunoTargets and Therapy 2021, 10:325-331

Published Date: 20 August 2021

Review

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma

Bughda R, Dimou P, D'Souza RR, Klampatsa A

ImmunoTargets and Therapy 2021, 10:313-323

Published Date: 5 August 2021

Review

Alopecia Areata: An Autoimmune Disease of Multiple Players

Suchonwanit P, Kositkuljorn C, Pomsoong C

ImmunoTargets and Therapy 2021, 10:299-312

Published Date: 29 July 2021

Review

Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology

Unterberger S, Davies KA, Rambhatla SB, Sacre S

ImmunoTargets and Therapy 2021, 10:285-298

Published Date: 28 July 2021

Review

Complement Inhibition and COVID-19: The Story so Far

Fodil S, Annane D

ImmunoTargets and Therapy 2021, 10:273-284

Published Date: 26 July 2021

Review

Cannabis and Autoimmunity: Possible Mechanisms of Action

Giorgi V, Marotto D, Batticciotto A, Atzeni F, Bongiovanni S, Sarzi-Puttini P

ImmunoTargets and Therapy 2021, 10:261-271

Published Date: 21 July 2021

Review

The Cancer-Immunity Cycle in Multiple Myeloma

Casey M, Nakamura K

ImmunoTargets and Therapy 2021, 10:247-260

Published Date: 16 July 2021

Review

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era

Kasarello K, Mirowska-Guzel D

ImmunoTargets and Therapy 2021, 10:237-246

Published Date: 7 July 2021